Rare Disease Diagnostics Market, By Technology (Genetic Testing, Molecular Diagnostics, Next-Generation Sequencing (NGS), Biochemical Assays, and Immunoassays), By Application, By End-user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4217
|
Published Date
July 2025
|
Pages
386
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Rare Disease Diagnostics Market size was valued at US$ 1,678.90 Million in 2024, expanding at a CAGR of 14.5% from 2025 to 2032.
The Rare Disease Diagnostics Market focuses on the development, production, and utilization of diagnostic tools and tests specifically designed to identify rare diseases, which affect a small portion of the population. These diseases are often genetic, chronic, and complex, making early and accurate diagnosis essential for effective treatment and management. The market encompasses a range of technologies, including genetic testing, molecular diagnostics, next-generation sequencing, and biochemical assays.
Market growth is driven by increasing awareness of rare diseases, technological advancements in diagnostics, and government initiatives supporting rare disease research. Additionally, the expansion of rare disease patient registries and collaborations between healthcare providers and diagnostic companies further fuel market development. Key challenges include the high cost of testing and limited accessibility in developing regions. However, the rise of personalized medicine and the integration of artificial intelligence in diagnostic processes are expected to significantly enhance market growth. Overall, the Rare Disease Diagnostics Market plays a critical role in improving patient outcomes and advancing precision healthcare.
Rare Disease Diagnostics Market- Market Dynamics
The increasing adoption of advanced genetic testing technologies is driving growth in the rare disease diagnostics market.
The growing adoption of advanced genetic testing technologies is a key driver of the Rare Disease Diagnostics Market. Technologies such as next-generation sequencing and whole-genome analysis enable faster and more precise identification of rare genetic disorders that were once difficult to diagnose. This leads to earlier and more accurate diagnoses, significantly improving patient outcomes and quality of life.
Advancements in genetic testing have also reduced costs and increased accessibility, encouraging broader adoption among healthcare providers and patients. Additionally, innovations like non-invasive prenatal testing and liquid biopsies are expanding the scope of diagnostic possibilities. This technological progress is further supported by increased research funding and regulatory approvals, driving sustained market growth. Overall, the integration of advanced genetic testing is revolutionizing rare disease diagnostics, making it more effective and accessible worldwide.
Governments globally are actively supporting this transformation through substantial investments and strategic initiatives. For instance, the European Union has allocated over €3.2 billion from 2007 to 2020 under its research and innovation framework programs to support more than 550 multinational research projects on rare diseases. The current Horizon Europe program continues this commitment, with €640 million dedicated to rare disease research in its 2021–2022 work programs.
Rare Disease Diagnostics Market- Key Insights
- According to our research analyst’s analysis, the global market is projected to grow at a compound annual growth rate (CAGR) of approximately 14.5% between 2025 and 2032.
- In 2024, the Genetic Testing segment is expected to hold the largest market share based on technology.
- Genetic Disorders emerged as the leading application segment in 2024.
- Hospitals and Clinics were the dominant end-users in 2024.
- North America was the top revenue-generating region in 2024.
Rare Disease Diagnostics Market- Segmentation Analysis:
The Global Rare Disease Diagnostics Market is segmented on the basis of Technology, Application, End-user, and Region.
The Rare Disease Diagnostics Market is segmented by technology into Genetic Testing, Molecular Diagnostics, Next-Generation Sequencing (NGS), Biochemical Assays, and Immunoassays. Among these, Genetic Testing is the most dominant segment due to its ability to directly analyze an individual’s DNA to identify mutations or variations responsible for rare genetic disorders. This technology provides precise and early diagnosis, which is critical for managing diseases that are often complex and difficult to detect through traditional diagnostic methods. Advances in genetic testing, including more affordable and rapid sequencing techniques, have greatly expanded its adoption among healthcare providers worldwide. Additionally, genetic testing supports personalized medicine by enabling tailored treatment plans based on an individual’s genetic profile. It is effective in diagnosing a broad spectrum of rare diseases, from inherited metabolic disorders to rare cancers, making it indispensable in clinical practice. Government support and increasing awareness have accelerated the integration of genetic testing into routine diagnostics, with the expansion of newborn screening programs and prenatal genetic tests further driving this segment\'s growth. Overall, genetic testing’s accuracy, speed, and expanding clinical applications firmly establish it as the leading technology in rare disease diagnostics.
On the application front, the market is divided into Genetic Disorders, Neurological Disorders, Metabolic Disorders, Rare Cancers, and Others. Genetic Disorders represent the most dominant application segment due to their origin in DNA abnormalities, often inherited from parents, which makes early and accurate diagnosis essential for effective disease management. This category includes a wide range of conditions such as cystic fibrosis, muscular dystrophy, and Huntington’s disease, all of which have significant impacts on patient health and quality of life. Diagnostic technologies like genetic testing and next-generation sequencing have proven especially effective in detecting these disorders by identifying specific gene mutations. Growing awareness among healthcare providers and patients about the importance of early diagnosis has further propelled demand in this segment. Moreover, government initiatives and rare disease advocacy groups have significantly contributed by funding research, improving access to diagnostics, and supporting policy frameworks. The increasing availability of targeted therapies also drives the need for precise genetic diagnoses. Newborn screening programs, often supported by national health agencies, have played a key role in early detection, thus expanding this segment. Collectively, the critical need for accurate identification and personalized treatment options makes genetic disorders the leading application segment in the rare disease diagnostics market.
Globally, governments are prioritizing rare disease diagnostics as part of public health strategies. For instance, the U.S. National Institutes of Health (NIH) supports the Rare Diseases Clinical Research Network to advance diagnostic technologies and treatment. The European Union’s Rare Disease Action Plan emphasizes early diagnosis and genetic testing to improve patient outcomes. Additionally, countries like Japan, Canada, and Australia have implemented national rare disease frameworks that include genetic screening and diagnostics. These government efforts underscore the critical role of genetic testing and drive the sustained growth of the rare disease diagnostics market worldwide.
Rare Disease Diagnostics Market- Competitive Landscape:
The Rare Disease Diagnostics Market is highly competitive, with leading players emphasizing innovation, strategic partnerships, and product portfolio expansion to maintain a strong market position. Companies such as Illumina, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, and Bio-Rad Laboratories dominate the market by investing heavily in research and development to enhance diagnostic accuracy and speed. Other notable companies, including Abbott Laboratories, Invitae Corporation, Myriad Genetics, and Natera, Inc., contribute through advanced genetic testing and molecular diagnostic solutions. Competition also involves collaborations with healthcare providers and academic institutions to accelerate rare disease research and improve diagnosis. Additionally, many firms are focused on increasing accessibility and reducing the costs of diagnostic tests to serve a wider patient population. This dynamic environment fosters continuous technological innovation and opens opportunities for emerging players to enter the market.
Recent Developments:
- In March 2025, Illumina launched the MiSeq i100 gene sequencer, designed to make genetic sequencing more affordable and accessible to smaller laboratories worldwide.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL RARE DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Illumina, Inc.
- Thermo Fisher Scientific
- Roche Diagnostics
- QIAGEN N.V.
- Bio-Rad Laboratories
- Abbott Laboratories
- Becton, Dickinson and Company
- Invitae Corporation
- Agilent Technologies
- PerkinElmer, Inc.
- Myriad Genetics
- Natera, Inc.
- F. Hoffmann-La Roche AG
- Guardant Health
- Twist Bioscience Corporation
- Laboratory Corporation of America Holdings (LabCorp)
- Charles River Laboratories
- Sophia Genetics
- Centogene AG
- Blueprint Genetics
GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Genetic Testing
- Molecular Diagnostics
- Next-Generation Sequencing (NGS)
- Biochemical Assays
- Immunoassays
GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Genetic Disorders
- Neurological Disorders
- Metabolic Disorders
- Rare Cancers
- Others
GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Academic and Government Research Centers
GLOBAL RARE DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Rare Disease Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Rare Disease Diagnostics Market Snippet by Technology
2.1.2. Rare Disease Diagnostics Market Snippet by Application
2.1.3. Rare Disease Diagnostics Market Snippet by End-user
2.1.4. Rare Disease Diagnostics Market Snippet by Country
2.1.5. Rare Disease Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Rare Disease Diagnostics Key Market Trends
3.1. Rare Disease Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Rare Disease Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Rare Disease Diagnostics Market Opportunities
3.4. Rare Disease Diagnostics Market Future Trends
4. Rare Disease Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Rare Disease Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Rare Disease Diagnostics Market Landscape
6.1. Rare Disease Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Rare Disease Diagnostics Market – By Technology
7.1. Overview
7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
7.1.2. Genetic Testing
7.1.3. Molecular Diagnostics
7.1.4. Next-Generation Sequencing (NGS)
7.1.5. Biochemical Assays
7.1.6. Immunoassays
8. Rare Disease Diagnostics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Genetic Disorders
8.1.3. Neurological Disorders
8.1.4. Metabolic Disorders
8.1.5. Rare Cancers
8.1.6. Others
9. Rare Disease Diagnostics Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
9.1.2. Hospitals and Clinics
9.1.3. Diagnostic Laboratories
9.1.4. Research Institutes
9.1.5. Academic and Government Research Centers
10. Rare Disease Diagnostics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Rare Disease Diagnostics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Rare Disease Diagnostics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Rare Disease Diagnostics Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Rare Disease Diagnostics Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Rare Disease Diagnostics Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Rare Disease Diagnostics Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Illumina, Inc.
11.2.2. Thermo Fisher Scientific
11.2.3. Roche Diagnostics
11.2.4. QIAGEN N.V.
11.2.5. Bio-Rad Laboratories
11.2.6. Abbott Laboratories
11.2.7. Becton, Dickinson and Company
11.2.8. Invitae Corporation
11.2.9. Agilent Technologies
11.2.10. PerkinElmer, Inc.
11.2.11. Myriad Genetics
11.2.12. Natera, Inc.
11.2.13. F. Hoffmann-La Roche AG
11.2.14. Guardant Health
11.2.15. Twist Bioscience Corporation
11.2.16. Laboratory Corporation of America Holdings (LabCorp)
11.2.17. Charles River Laboratories
11.2.18. Sophia Genetics
11.2.19. Centogene AG
11.2.20. Blueprint Genetics
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
